Components

Xilinx Announces Integration of 56G PAM4 Transceiver Technology into its Virtex UltraScale+ FPGAs

Today announced integration of 56G PAM4 transceiver technology into its industry-leading Virtex® UltraScale+™ FPGAs. Built upon proven 16nm FinFET+ FPGA fabric, these devices will expand the Virtex product line to drive the next wave of Ethernet deployment and provide seamless migration of existing systems to next-gen backplane, optics, and high performance interconnects.

Targeted for wired communications, data centers, and wireless backhaul applications, the integrated devices enable customers to double bandwidth on existing infrastructure by breaking through the physical limitations of data transmission at 56G+ line rates.

“Xilinx is leading the charge on transceiver technology with the infusion of 56G PAM4 into our 16nm FPGAs,” said Ken Chang, vice president, SerDes Technology Group at Xilinx. “These new devices are built upon a proven FPGA foundation and are in alignment with the vast ecosystem of optics, ASICs, and backplanes soon to be deployed.”

Today’s announcement signals another milestone for Xilinx transceiver leadership after the company was first to demonstrate 56G PAM4 transceiver technology on a 16nm programmable device in 2016. View the Xilinx 56G PAM4 technology demo and contact your local sales representative for more information.

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

2 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

3 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

3 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

3 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

6 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

6 days ago